Cardiac stem cell treatment in myocardial infarction: protocol for a systematic review and meta‐analysis of preclinical studies
Evidence-based Preclinical Medicine · 2015
DOI: 10.1002/ebm2.9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Evidence-based Preclinical Medicine, 2015. Verfasst von P. P. Zwetsloot und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medical Center Utrecht, Dutch Ministry of Economic Affairs, Agriculture and Innovation, Netherlands CardioVascular Research Initiative.
Abstract (Originalsprache)
Cardiac‐derived stem or progenitor cells ( CSCs ) have emerged as a possible therapeutic intervention for myocardial infarction, potentially ameliorating the devastating effects caused by inadequate blood flow to the heart. The first human clinical trials using these myocardial‐derived cells have recently started, but scientific controversy exists regarding the efficacy and origin of some of these stem cells in preclinical animal models. Systematic review of the current literature on CSCs in ischaemic cardiomyopathy can provide useful additional information on the use of CSCs in preclinical trials. By combining all available data, we can adequately compare the different types of cells being used and possibly identify factors that influence cardiac stem cell therapy in general. This protocol provides a thorough description of the methodology that will be used in our systematic review and meta‐analysis of all preclinical animal studies involving cardiac stem cell treatment for ischaemic cardiomyopathy.
Förderung
- University Medical Center Utrecht
- Dutch Ministry of Economic Affairs, Agriculture and Innovation
- Netherlands CardioVascular Research Initiative
Zitieren
APA
Zwetsloot, P. P., Lorkeers, S. J. J. O., Végh, A. M. D., Hout, G. P. J. V., Currie, G. L., Goumans, M. J., Chamuleau, S. A. J., & Sluijter, J. P. G. (2015). Cardiac stem cell treatment in myocardial infarction: protocol for a systematic review and meta‐analysis of preclinical studies. Evidence-based Preclinical Medicine. https://doi.org/10.1002/ebm2.9
Vancouver
Zwetsloot PP, Lorkeers SJJO, Végh AMD, Hout GPJV, Currie GL, Goumans MJ, et al. Cardiac stem cell treatment in myocardial infarction: protocol for a systematic review and meta‐analysis of preclinical studies. Evidence-based Preclinical Medicine. 2015. doi:10.1002/ebm2.9
BibTeX
@article{Zwetsloot2015,
author = {Zwetsloot, P. P. and Lorkeers, S. J. Jansen of and Végh, A. M. D. and Hout, G. P. J. van and Currie, G. L. and Goumans, M. J. and Chamuleau, S. A. J. and Sluijter, J. P. G.},
title = {Cardiac stem cell treatment in myocardial infarction: protocol for a systematic review and meta‐analysis of preclinical studies},
journal = {Evidence-based Preclinical Medicine},
year = {2015},
doi = {10.1002/ebm2.9}
}
EUVIMED